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Vitamin D3 (cholecalciferol) plays an important role in calcium, 
phosphate, and bone metabolism. Vitamin D3, either synthesized 
endogenously or derived from alimentary sources, is first acti-
vated through sequential hydroxylations by vitamin D3 25-hy-
droxylase in the liver and 25-hydroxyvitamin D3 1α-hydroxylase 
(CYP27B1) in the kidney to 25-OH-D3 and 1,25(OH)2D3 (cal-
citriol), respectively. Calcitriol – the active vitamin D deriva-
tive – regulates calcium metabolism by acting on nuclear and 
extranuclear vitamin D receptors (VDR). Apart from mineral 
metabolism, vitamin D is involved in many other processes such 
as cell proliferation, inflammatory and immune reactions, glu-
cose and lipid metabolism, etc. Indeed, VDR are expressed in 
virtually all tissues and vitamin D deficiency is suggested to con-
tribute to the pathogenesis of various diseases including certain 
types of cancer, inflammatory bowel disease, multiple sclerosis, 
peridontal diseases, diabetes, hypertension, atherosclerosis and 
neurodegenerative diseases (see below). In addition, vitamin D 
supplementation is beneficial in humans with at least some of 
these disorders and in animal experimental models of them (1-
3).
Several lines of evidence suggest the link between vitamin D 
and adipose tissue. First, both CYP27B1 and VDR are expressed 
in the adipose tissue. Second, calcitriol has been demonstrated 
to regulate various aspects of adipose tissue function such as 
preadipocyte proliferation/differentiation, fat storage, adipokine 
secretion, cortisol/cortisone interconversion and local inflam-
matory reaction, although the results of these studies are some-
times controversial. Third, decrease in serum 25-OH-D3 (the 
best marker of vitamin D supply) was observed in obese indi-
viduals. This vitamin D insufficiency was attributed to various 
factors such as reduced exposure to sunlight due to sedentary 
lifestyle, sequestration of lipohilic vitamin in fat tissue, insulin 
resistance or hyperleptinemia (4, 5).
Infiltration of adipose tissue with activated macrophages is a 
hallmark of obesity, and macrophage-derived factors are respon-
sible for many abnormalities of adipocyte function observed in 
obese individuals. In this issue of Adipobiology, Paul Trayhurn 
with his colleagues present very interesting findings about the 
influence of macrophages on vitamin D system in adipocytes 
(6). By using a microarray approach, they demonstrated that 
macrophage conditioned medium increases the expression of 
CYP27B1 and VDR mRNA in adipocytes. These results suggest 
that macrophage-derived factors may stimulate local vitamin 
D signaling in the adipose tissue. Several question arise while 
analyzing these data. First, it is unclear if changes of mRNA ex-
pression are mirrored at the protein level. Second, it is interest-
ing if the same is observed in macrophage-infiltrated adipose 
tissue in obese animals and humans in vivo. In contrast to in 
vitro conditions, in vivo adipocytes are exposed to many other 
factors in addition to macrophage-derived, such as hypoxia, hy-
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perinsulinemia/insulin resistance, altered profile of adipokines, 
abnormal plasma lipid and/or glucose level; at least some of 
them may influence vitamin D system. Even if CYP27B1 and 
VDR are up-regulated in vivo, it will not necessarily result in 
enhanced vitamin D signaling. As stated before, circulating 25-
OH-D3 is often reduced in obesity. In general, it is assumed that 
extrarenal 1α-hydroxylase is less regulated than renal enzyme, 
and the amount of locally produced calcitriol is more depend-
ent on systemic concentration of its immediate precursor 25-
OH-D3 (although up-regulation of CYP27B1 by proinflamma-
tory cytokines in macrophages is a well-known phenomenon). 
Thus, local 1,25(OH)2D3 in adipose tissue may be unchanged or 
even reduced despite greater local CYP27B1 expression. Thus, it 
would be interesting to measure local calcitriol concentration in 
adipose tissue of obese subjects. As suggested (6), up-regulation 
of vitamin D signaling may be a compensatory response aimed 
to reduce local inflammation. Recently, we have demonstrated 
that small doses of 1,25(OH)2D3 which have no effect on cal-
cium metabolism increase insulin sensitivity in healthy rats (7). 
Not only fasting serum insulin was reduced (suggestive of in-
creased insulin sensitivity of the liver) and glucose disposal rate 
in hyperinsulinemic euglycemic clamp was increased (indica-
tive of skeletal muscle insulin sensitization), but also decrease in 
plasma nonesterified fatty acids and glycerol were noted, which 
is the evidence of improved ability of insulin to suppress adi-
pose tissue lipolysis. In addition, vitamin D supplementation in-
creased insulin sensitivity in some interventional human studies 
(8). Thus, up-regulation of vitamin D3 in adipocytes may also 
counteract insulin resistance induced by macrophage activation. 
However, on the other hand, the recent study has demonstrated 
that targeted overexpression of VDR in adipocytes results in 
reduced lipolysis, decrease in energy expenditure and obesity 
(9). Thus, it cannot be definitely concluded if up-regulation of 
vitamin D signaling in adipocytes is beneficial or detrimental. 
In any case, local vitamin D system in adipose tissue needs to 
be examined in more detail since it may significantly contrib-
ute to adipose dysfunction associated with obesity and is also 
a potential target for therapy. Another intriguing target might 
be the association between vitamin D3 and nerve growth fac-
tor (NGF) (10,11) including the possible role of vitamin D3 in 
adipose-derived NGF (12) 
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